Al-Moudawi welcomes new opportunities. We are committed to being the first choice for pharmaceutical and aesthetic companies in the Iraqi market.
Contact us now by clicking the button below, or send us an email at [email protected]
Al Moudawi pharmaceuticals was founded in 2013 with the synergy of two groups that have more than 50 years experience in the medical and pharmaceutical fields.The expertise in the medical and OTC promotion along with the knowledge of the Iraqi market and its dynamics brought these two groups together to create a company that guarantees internationally recognized quality.Our Mission is to ensure the availability of high-quality branded pharmaceuticals and medical aesthetics to those who need it across Iraq at the right place and at the right time.
Al Moudawi is thrilled to announce that it has achieved the prestigious ISO 9001 certification. Committed to delivering top-notch services, this certification reflects our unwavering dedication to quality, efficiency, and customer satisfaction.
AlMoudawi Pharmaceutical is proud to announce that it has successfully obtained the Good Distribution Practice (GDP) certification. This significant milestone underscores our unwavering commitment to delivering safe, high-quality medicines to patients worldwide.The GDP certification is a testament to AlMoudawi Pharmaceutical's adherence to the strictest international standards for the distribution of pharmaceutical products. It validates our robust quality management systems, efficient supply chain operations, and dedicated team of professionals.
A diversified portfolio of internationaly trusted brands
A portfolio of premium-quality, and world-renowned brands
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics, and other areas of unmet need.
At Allergan Aesthetics, an AbbVie company, we develop, manufacture, and market a portfolio of leading aesthetics brands and products. Our aesthetics portfolio includes facial injectables, body contouring, plastics, skin care, and more. Our product line includes BOTOX® Cosmetic (onabotulinumtoxinA) and JUVÉDERM® Collection of Fillers. With our own research and development team focused on driving innovation in aesthetics, we’re committed to providing the most comprehensive science-based product offerings available.
We are an international company based in Parma, with more 80 years of experience and a strong focus on research, development, production and the commercialisation of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas.Its R&D centres in Parma (Italy), Paris (France), Cary (USA), Chippenham and Oxford (UK) and Lidingö (Sweden) part of the acquisition of protein therapeutics biotech Zymenex in 2013. We export to more than 80 countries with a direct presence in 28.The Chiesi Group employs approximately 5,624 people, 788 of whom are dedicated to R&D activities and 827 of whom work at production sites in Italy, France and Brazil.
EMA Aesthetics is an innovation-driven aesthetics company specializing in advanced skincare technologies. Built on 18 years of industry expertise, the company introduced Préime, a premium aesthetics concept combining high-performance dermaceutical formulations with an advanced facial treatment device. EMA Aesthetics delivers comprehensive skin, body, and scalp care solutions supported by strong marketing and continuous technical training. Operating in more than 30 countries, the company continues its global expansion through a network of partners united by a shared vision of aesthetics as both science and art.
Ilko Pharmaceuticals (İlko İlaç), part of Selçuklu Holding, is a leading Turkish pharmaceutical company recognized for innovation, strong R&D investment, and advanced manufacturing capabilities. The company develops and produces prescription medicines, consumer health products under the Wellcare brand, and biotechnology therapies including biosimilars. İlko operates EU-GMP certified facilities in Konya, including specialized oncology and biotech units.
ITICO Pharma is an integrated healthcare company focused on developing, manufacturing, and distributing high-quality pharmaceutical products and treatment solutions. the company prioritizes patient well-being through accessible medicines and informed care. As it prepares to launch an advanced manufacturing facility, ITICO Pharma is positioning itself as a cost-effective regional hub meeting international standards. With a strong Middle East and Africa presence, it emphasizes ethical practices, portfolio diversity, scalability, and strategic partnerships globally sustainably.
NPI pioneered pharmaceutical manufacturing in Oman and evolved into a research-driven company focused on innovation and quality. It operates manufacturing sites in three countries producing oral solids, liquids, dry powders, and sachets across multiple therapeutic areas. NPI holds US FDA, EU GMP, and ISO 9001:2015 certifications. The company has a strong presence across GCC, MENA, Africa, CIS, Southeast Asia, Europe, the UK, and USA. It continues expanding as a trusted global pharmaceutical partner delivering high-quality medicines worldwide to patients globally.
Al Moudawi engages in numerous operations to ensure its commitment to its stakeholders:
Read More